Form 8-K - Current report:
SEC Accession No. 0001144204-19-038565
Filing Date
2019-08-08
Accepted
2019-08-08 16:15:22
Documents
3
Period of Report
2019-08-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv527154_8k.htm 8-K 20402
2 EXHIBIT 99.1 tv527154_ex99-1.htm EX-99.1 66552
3 GRAPHIC image_001.jpg GRAPHIC 20409
  Complete submission text file 0001144204-19-038565.txt   116304
Mailing Address 21 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 21 FIRSTFIELD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

EIN.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26770 | Film No.: 191009695
SIC: 2836 Biological Products, (No Diagnostic Substances)